Evidence map›Paper›PMID 32024980›Full record

ArticleCell death and differentiation2020

Correction: Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway.

Chao Liu, Zhaoying Yao, Jianing Wang, Wen Zhang, Yan Yang, Yan Zhang, Xinliang Qu, Yubing Zhu, Jianjun Zou, Sishi Peng and 7 more

Open access · bronzeAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death and differentiation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Current insight into the regulation of PD-L1 in cancer.Experimental hematology & oncology · 2022
    Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Chao Liu *Department of Pharmacy, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, PR China.
Zhaoying Yao *Department of Pharmacy, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, PR China.
Jianing Wang *Neurobiology Laboratory, Jiangsu Center for Drug Screening, China Pharmaceutical University, Nanjing, 210009, PR China.
Wen ZhangDepartment of Pharmacy, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, PR China.
Yan YangDepartment of Pharmacy, The Third People's Hospital of Chengdu & Affiliated Hospital of Southwest Jiaotong University, 82 Qing Long Street, Chengdu, 610031, PR China.
Yan ZhangDepartment of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, PR China.
Xinliang QuDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, PR China.
Yubing ZhuDepartment of Pharmacy, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, PR China.
Jianjun ZouDepartment of Pharmacy, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, PR China.
Sishi PengDepartment of Clinical Pharmacy, School of Basic Medicine & Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, PR China.
Yan ZhaoDepartment of Pharmacy, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, PR China.
Shuli ZhaoGeneral Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, PR China.
Bangshun HeGeneral Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, PR China.
Qiongyu MiGeneral Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, PR China.
Xiuting LiuDepartment of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Xu ZhangDepartment of Pharmacy, The First People's Hospital of Chengdu & Affiliated Hospital of Chengdu Medical College, 18 Wanxiang East Road, Chengdu, 610041, PR China. Jason151X7@stu.cpu.edu.cn.
Qianming DuGeneral Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, PR China. duqianming@njmu.edu.cn.ORCID http://orcid.org/0000-0002-1092-2899
China Pharmaceutical University · CNNanjing Medical University · CNFirst Affiliated Hospital of Chengdu Medical College · CNThird People's Hospital of Chengdu · CNWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32024980
PMCPMC7413370
OpenAlexW2994401605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.